AUPH
Aurinia Pharmaceuticals Inc
16.40$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6,080.6% | -7,560.0% | -10,816.8% | -9,802.1% | -11,146.9% | -19,995.3% | -139.4% | -345.8% | -59.3% | -19.1% | 18.9% | 47.9% | |
| 547.1% | 663.0% | 854.9% | 346.7% | 338.0% | 368.2% | 2.7% | 6.1% | 2.0% | 6.6% | 8.3% | 3.3% | |
| 786.3% | 1,371.9% | 799.4% | 1,010.0% | 1,481.6% | 2,331.4% | 34.8% | 68.5% | 24.1% | 25.8% | 13.4% | 5.2% | |
| 853.6% | -824.7% | 565.3% | 6,813.8% | 1,329.2% | 6,792.5% | 40.2% | 92.4% | 24.4% | – | – | – | |
| -802.2% | 519.6% | 849.7% | 404.5% | -1,295.9% | 638.1% | 9.0% | -47.4% | -5.1% | -3.2% | 2.3% | -3.1% | |
| 32.4% | 21.3% | 14.5% | 6.0% | 16.2% | 31.8% | 14.7% | 3.3% | 0.2% | 0.4% | 0.1% | 0.1% | |
| -3,627.3% | -9.8% | 5,775.1% | -1,905.5% | -14.3% | 2,447.5% | -315.6% | -227.8% | -45.2% | -3.8% | 16.7% | -11.6% | |
| 17,802.2% | 357.0% | 1,163.0% | 41,702.9% | 867.0% | 76,684.0% | 387.8% | 484.8% | 0.0% | 0.0% | -17.1% | -34.7% | |
| -575.5% | – | -73.4% | -30.2% | -27.4% | -39.9% | – | 0.0% | 0.0% | -5.7% | -5.1% | -4.6% | |
| 17,226.6% | 357.0% | 24,632.9% | 41,702.9% | 867.0% | 76,683.6% | 387.8% | 484.8% | 1.8% | -2.9% | -20.9% | -37.5% | |
| 7,512.6% | -7,212.8% | 19,591.3% | 29,995.2% | -10,294.2% | 59,135.8% | -67.2% | -88.7% | -102.8% | -25.8% | 14.7% | -1.1% | |
| -6,112.9% | -7,581.3% | -10,831.2% | -9,808.1% | -11,163.1% | -20,027.0% | -154.0% | -349.1% | -59.6% | -19.5% | 18.8% | 47.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.